Antagonis Biotherapeutics
Vienna, Austria· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Antagonis Biotherapeutics is a privately held biotherapeutics company based in Graz, Austria, founded in 2021. The company develops protein-based glycan antagonists called GAGbodies™, targeting glycosaminoglycans (GAGs) for immuno-oncology applications, with a focus on inhibiting metastasis. Its unique platform leverages a proprietary database of GAG-binding proteins and a human GAG oligosaccharide library to engineer high-affinity, specific therapeutic candidates.
Biologics